Ready to play
Ready to play
Moderna, the American company, lost around 10% of its market value after issuing warnings that its potential COVID-19 vaccine could cause unexpected side effects. The company confirmed that it is assessing the safety and efficacy of the vaccine, and preliminary results show some side effects. However, these concerns led to a significant decline in the company's shares on global markets.
Notice: This Is an AI-Generated Summary
Comments (0)